高衰弱指数患者在大胃肠手术后可良好依从加速康复路径并改善30天结局
本研究纳入约翰霍普金斯两院区加速康复路径实施后接受腹部手术并录入ACS NSQIP数据库的患者,采用改良5项衰弱指数评估风险。结果显示高衰弱(mFI≥2)与低衰弱患者高依从比例相似,高依从与高衰弱患者住院时间缩短及主要并发症减少独立相关。
要点
- 高衰弱患者对加速康复路径的依从性与低衰弱患者相当。
- 高依从独立关联高衰弱患者住院时间缩短和主要并发症减少。
- 低依从者较少实现目标导向治疗、术后当日及第1-2天活动、第1天进固体饮食和拔除导尿管。
核心结论
- 衰弱患者对稳健的加速康复路径依从性良好,并因此获得结局改善。
- 针对特定加速康复路径标准的最大化依从干预可能进一步改善该人群结局。
研究设计与样本
- 纳入ACS NSQIP数据库中在两家约翰霍普金斯医院实施加速康复路径后接受腹部手术的患者。
- 使用ACS NSQIP验证的改良5项衰弱指数评估风险。
- 主要结局包括对14项加速康复路径标准的依从性、术后住院时间、主要并发症(Clavien-Dindo II-IV级)和30天再入院。
- 纳入646例参与加速康复路径项目的患者和65例路径实施前mFI≥2的患者。
主要发现
- 325例(50.3%)为高依从者(依从性>75%)。
- mFI≥2与mFI<2患者达到高依从的比例相似(51.6% vs 50.2%,P=.89)。
- 高衰弱评分(mFI≥2)低依从者较高依从者目标导向治疗使用显著更少(43% vs 75%,P=.01)。
- 低依从者较高依从者手术当日活动(43% vs 78%,P=.01)、术后第1天活动(43% vs 88%,P<.01)、术后第2天活动(60% vs 100%,P<.01)比例更低。
- 低依从者较高依从者术后第1天进固体饮食(17% vs 59%,P<.01)和术后第1天拔除导尿管(45% vs 97%,P<.01)比例更低。
临床怎么用
- 对高衰弱指数患者也应积极实施加速康复路径,不应因衰弱而降低路径执行力度。
- 重点关注目标导向治疗、术后当日及第1-2天活动、术后第1天进固体饮食和拔除导尿管等依从性薄弱环节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced recovery pathways have been shown to improve clinical outcomes after surgery. Concerns exist about the feasibility of implementing enhanced recovery pathways in frail patients, who are at a greater risk for adverse postoperative outcomes. This study evaluated compliance and outcomes after enhanced recovery pathway implementation in high-risk, abdominal surgery patients. METHODS: Patients entered into the American College of Surgeons National Surgical Quality Improvement Program database who underwent abdominal surgery after enhanced recovery pathway implementation at two Johns Hopkins Medical Institutions were included. Risk was assessed using the American College of Surgeons National Surgical Quality Improvement Program validated, modified 5-item frailty index. Primary outcomes included compliance with 14 enhanced recovery pathway standards and postoperative length of stay, major complications (Clavien-Dindo score II-IV), and 30-day readmission. RESULTS: This study included 646 patients who participated in our enhanced recovery pathway program and 65 patients with modified 5-item frailty index ≥ 2 before enhanced recovery pathway implementation. Overall, 325 patients (50.3%) were high compliers (>75% compliance) with enhanced recovery pathway standards, with similar proportions of patients with a modified 5-item frailty index ≥ 2 or < 2 achieving high compliance (51.6% vs 50.2%, P = .89, respectively). Examining causality for "low compliers" among patients with a high frailty score (modified 5-item frailty index ≥2) demonstrated significant less use of goal-directed therapy when compared with "high compliers" (43% vs 75%, P = .01). Low compliers were also less likely than high compliers to experience mobilization the day of surgery (43% vs 78%, P = .01), postoperative day 1 (43% vs 88%, P < .01), and postoperative day 2 (60% vs 100%, P < .01). In addition, low compliers were less likely than high compliers to have their diet advanced to solids on postoperative day 1 (17% vs 59%, P < .01) and have their Foley catheter removed on postoperative day 1 (45% vs 97%, P < .01). Comparing our pre-enhanced recovery pathway patients with our enhanced recovery pathway cohort with a high frailty score, enhanced recovery pathway patients had a significantly shorter length of stay (4.5 vs 6 days, P = .04). However, adjusted analysis demonstrated that high compliance, and not just the enhanced recovery pathway intervention among patients with a high frailty score, was independently associated with a decrease in length of stay (odds ratio 0.72, 95% confidence interval 0.63-0.82, P < .01) and a significant reduction in major complications (odds ratio 0.30, 95% confidence interval 0.14-0.65, P < .01. CONCLUSION: This study demonstrates that frail patients comply well with a robust enhanced recovery pathway protocol and subsequently experience improved outcomes. Targeted interventions that seek to maximize compliance with specific enhanced recovery pathway standards may further improve outcomes in this population.
引用
- Hampton JP, Owodunni OP, Bettick D, et al. Compliance to an enhanced recovery pathway among patients with a high frailty index after major gastrointestinal surgery results in improved 30-day outcomes. Surgery. 2019. PMID: 30885399. doi:10.1016/j.surg.2019.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。